SAGE : Sage Therapeutics stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2023-02-01 |
|---|---|---|---|---|
| 2023 | $57.24 | $46.95 | $63.35 | 28.17% |
| 2024 | $51.08 | $49.02 | $57.1 | 14.36% |
| 2025 | $48.85 | $48.02 | $49.61 | 9.38% |
| 2026 | $46.62 | $46.21 | $47.6 | 4.4% |
| 2027 | $42.59 | $36.68 | $46.7 | -4.64% |
| 2028 | $30.49 | $26.71 | $35.42 | -31.73% |
| 2029 | $21.91 | $18.65 | $26.03 | -50.94% |
| 2030 | $24.86 | $18.71 | $32.48 | -44.33% |
| 2031 | $44.46 | $35.27 | $51.72 | -0.46% |
| 2032 | $36.66 | $35.93 | $37.54 | -17.91% |
| 2033 | $37.94 | $37.79 | $38.08 | -15.05% |
The 29 Wall Street analysts offering Sage Therapeutics stock forecast in the last 6 months have average price target of
$15.83 with a high forecast of $52.0 and a low forecast of $4.0.
The average Sage Therapeutics stock forecast represents a -64.55%
decrease from the last price of $44.6599998474121.
For Sage Therapeutics stock forecast for 2023, 10 predictions are offered for each month of 2023 with average Sage Therapeutics stock
forecast of $57.24, a high forecast of $63.35, and a low forecast of $46.95.
The average Sage Therapeutics stock forecast 2023 represents a 28.17%
increase from the last price of $44.6599998474121.
For Sage Therapeutics stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Sage Therapeutics stock
forecast of $51.08, a high forecast of $57.1, and a low forecast of $49.02.
The average Sage Therapeutics stock forecast 2024 represents a 14.36%
increase from the last price of $44.6599998474121.
For Sage Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Sage Therapeutics stock
forecast of $46.62, a high forecast of $47.6, and a low forecast of $46.21.
The average Sage Therapeutics stock forecast 2026 represents a 4.4%
increase from the last price of $44.6599998474121.
For Sage Therapeutics stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Sage Therapeutics stock
forecast of $30.49, a high forecast of $35.42, and a low forecast of $26.71.
The average Sage Therapeutics stock forecast 2028 represents a -31.73%
decrease from the last price of $44.6599998474121.
For Sage Therapeutics stock forecast 2029, 12 predictions are offered for each month of 2029 with average Sage Therapeutics stock
forecast of $21.91, a high forecast of $26.03, and a low forecast of $18.65.
The average Sage Therapeutics stock forecast 2029 represents a -50.94%
decrease from the last price of $44.6599998474121.
For Sage Therapeutics stock forecast for 2033 (10 year), 2 predictions are offered for each month of 2033 with average Sage Therapeutics stock
forecast of $37.94, a high forecast of $38.08, and a low forecast of $37.79.
The average Sage Therapeutics stock forecast 2033 represents a -15.05%
decrease from the last price of $44.6599998474121.
Please, see more forecasts below.
SAGE : Sage Therapeutics stock forecast by Wall Street Analysts
The average Sage Therapeutics stock forecast from last 6 month is $15.83, and this show a -21.24% decrease in average from the prior price target of the each prediction. Also, this average forecast of $15.83 represents a -23.12% decrease from the past average forecast of $20.59, 6 months ago from 22 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-11-21 | RBC Capital | $4.0000 | $4.0000 | Sector Perform |
| 2024-11-21 | TD Cowen | $10.00 | $9.0000 | Hold |
| 2024-11-20 | Needham | Hold | ||
| 2024-11-20 | HC Wainwright & Co. | $14.00 | $14.00 | Neutral |
| 2024-10-30 | Needham | Hold | ||
| 2024-10-30 | HC Wainwright & Co. | $25.00 | $14 | Neutral |
| 2024-10-30 | Truist Securities | $13.00 | $8 | Hold |
| 2024-10-30 | Oppenheimer | $9.0000 | $8 | Perform |
| 2024-10-30 | Piper Sandler | $52.0000 | $26 | Overweight |
| 2024-10-30 | Scotiabank | $17.00 | $14.0000 | Sector Outperform |
| 2024-10-17 | Needham | Hold | ||
| 2024-10-10 | Raymond James | Market Perform | ||
| 2024-10-09 | B of A Securities | $11.0000 | $6 | Underperform |
| 2024-10-09 | Wedbush | $9.0000 | $8 | Neutral |
| 2024-10-09 | HC Wainwright & Co. | $25.00 | $25.00 | Neutral |
| 2024-10-09 | Baird | $13.00 | $9 | Neutral |
| 2024-10-08 | Needham | Hold | ||
| 2024-10-04 | RBC Capital | $10.0000 | $4 | Underperform |
| 2024-08-14 | Truist Securities | $18.00 | $13 | Hold |
| 2024-08-06 | JP Morgan | $12.00 | $10.0000 | Neutral |
| 2024-08-02 | HC Wainwright & Co. | $25.00 | $25 | Neutral |
| 2024-08-01 | Needham | Hold | ||
| 2024-08-01 | Piper Sandler | $70.0000 | $52.0000 | Overweight |
| 2024-07-30 | TD Cowen | $16.00 | $10.0000 | Hold |
| 2024-07-26 | Goldman Sachs | $19.00 | $11 | Neutral |
| 2024-07-25 | HC Wainwright & Co. | $25.00 | $25.00 | Neutral |
| 2024-07-25 | Baird | $15.00 | $13 | Neutral |
| 2024-07-25 | JP Morgan | $18.00 | $12.0000 | Neutral |
| 2024-07-25 | Scotiabank | $19.00 | $17.0000 | Sector Outperform |
| 2024-07-24 | Needham | Hold | ||
| 2024-07-19 | Mizuho | $18.00 | $16 | Neutral |
| 2024-07-12 | JP Morgan | $23.00 | $18.0000 | Overweight |
| 2024-07-02 | HC Wainwright & Co. | $25.00 | $25.00 | Neutral |
| 2024-06-28 | Needham | Hold | ||
| 2024-06-20 | JP Morgan | $28.00 | $23 | Overweight |
| 2024-06-12 | HC Wainwright & Co. | $25.0000 | $25 | Neutral |
| 2024-06-11 | Baird | $15.00 | $15 | Neutral |
| 2024-06-11 | Needham | Hold | ||
| 2024-05-29 | Baird | $15.0000 | Neutral | |
| 2024-05-29 | Citigroup | $8.0000 | Sell | |
| 2024-05-01 | JP Morgan | $29.00 | $28.0000 | Overweight |
| 2024-04-26 | Goldman Sachs | $28.0000 | $19 | Neutral |
| 2024-04-26 | HC Wainwright & Co. | $28.00 | $25.0000 | Neutral |
| 2024-04-26 | RBC Capital | $26.00 | $15.0000 | Sector Perform |
| 2024-04-26 | Truist Securities | $22.0000 | $18 | Hold |
| 2024-04-26 | Canaccord Genuity | $21.00 | $17.0000 | Hold |
| 2024-04-26 | Needham | Hold | ||
| 2024-04-26 | Mizuho | $20.00 | $18.0000 | Neutral |
| 2024-04-25 | Needham | Hold | ||
| 2024-04-18 | Needham | Hold | ||
| 2024-04-18 | TD Cowen | $30.0000 | $16.0000 | Buy |
| 2024-04-18 | Oppenheimer | $25.0000 | $17 | Perform |
| 2024-04-18 | Scotiabank | $34.0000 | $19.0000 | Sector Outperform |
| 2024-04-17 | B of A Securities | $24.00 | $14.0000 | Underperform |
| 2024-04-17 | HC Wainwright & Co. | $28.00 | Neutral | |
| 2024-04-17 | Wedbush | $24.0000 | Neutral | |
| 2024-03-26 | JP Morgan | $24.0000 | $29 | Overweight |
| 2024-03-11 | RBC Capital | $26.0000 | Sector Perform | |
| 2024-02-28 | Morgan Stanley | $20.00 | $22.0000 | Equal-Weight |
| 2024-02-15 | RBC Capital | $21.00 | $26.0000 | Sector Perform |
| 2024-02-15 | HC Wainwright & Co. | $25.0000 | $28.0000 | Neutral |
| 2023-12-18 | Stifel | $22.00 | $20 | Hold |
| 2023-12-12 | Deutsche Bank | $21.0000 | Hold |
Sage Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-02-02 | $44.25 | -0.91% |
| 2023-02-03 | $43.69 | -1.27% |
| 2023-02-06 | $42.97 | -1.66% |
| 2023-02-07 | $42.46 | -1.18% |
| 2023-02-08 | $41.90 | -1.32% |
SAGE : Long term Sage Therapeutics stock forecast for 2024 - 2025 - 2030
Forecast for 2023 Mar. is $46.95 , for 2024 Feb. is $54.55 , for 2027 Feb. is $46.34 , for 2028 Feb. is $34.23 , for 2032 Feb. is $36.90 , and for 2033 Feb. is $38.08.
SAGE : Sage Therapeutics stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Mar. | $46.95 | 5.13% |
| 2023 Apr. | $49.82 | 6.10% |
| 2023 May. | $52.60 | 5.58% |
| 2023 Jun. | $55.41 | 5.34% |
| 2023 Jul. | $58.31 | 5.24% |
| 2023 Aug. | $61.12 | 4.82% |
| 2023 Sep. | $63.09 | 3.23% |
| 2023 Oct. | $63.35 | 0.40% |
| 2023 Nov. | $62.02 | -2.10% |
| 2023 Dec. | $59.73 | -3.70% |
SAGE : Sage Therapeutics stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $57.10 | -4.39% |
| 2024 Feb. | $54.55 | -4.48% |
| 2024 Mar. | $52.33 | -4.06% |
| 2024 Apr. | $50.59 | -3.33% |
| 2024 May. | $49.47 | -2.21% |
| 2024 Jun. | $49.02 | -0.91% |
| 2024 Jul. | $49.18 | 0.33% |
| 2024 Aug. | $49.81 | 1.27% |
| 2024 Sep. | $50.50 | 1.40% |
| 2024 Oct. | $50.71 | 0.41% |
| 2024 Nov. | $50.28 | -0.85% |
| 2024 Dec. | $49.34 | -1.87% |
SAGE : Sage Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $48.41 | -1.89% |
| 2025 Feb. | $48.02 | -0.81% |
| 2025 Mar. | $48.20 | 0.38% |
| 2025 Apr. | $48.66 | 0.96% |
| 2025 May. | $49.14 | 0.98% |
| 2025 Jun. | $49.48 | 0.68% |
| 2025 Jul. | $49.61 | 0.26% |
| 2025 Aug. | $49.54 | -0.13% |
| 2025 Sep. | $49.33 | -0.43% |
| 2025 Oct. | $49.03 | -0.62% |
| 2025 Nov. | $48.63 | -0.81% |
| 2025 Dec. | $48.13 | -1.02% |
SAGE : Sage Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $47.60 | -1.12% |
| 2026 Feb. | $47.06 | -1.14% |
| 2026 Mar. | $46.59 | -0.99% |
| 2026 Apr. | $46.31 | -0.60% |
| 2026 May. | $46.21 | -0.21% |
| 2026 Jun. | $46.23 | 0.04% |
| 2026 Jul. | $46.32 | 0.18% |
| 2026 Aug. | $46.43 | 0.24% |
| 2026 Sep. | $46.55 | 0.27% |
| 2026 Oct. | $46.66 | 0.24% |
| 2026 Nov. | $46.76 | 0.20% |
| 2026 Dec. | $46.79 | 0.08% |
SAGE : Sage Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $46.70 | -0.20% |
| 2027 Feb. | $46.34 | -0.77% |
| 2027 Mar. | $45.72 | -1.34% |
| 2027 Apr. | $45.09 | -1.38% |
| 2027 May. | $44.46 | -1.39% |
| 2027 Jun. | $43.70 | -1.72% |
| 2027 Jul. | $42.77 | -2.12% |
| 2027 Aug. | $41.73 | -2.43% |
| 2027 Sep. | $40.58 | -2.77% |
| 2027 Oct. | $39.31 | -3.12% |
| 2027 Nov. | $38.00 | -3.34% |
| 2027 Dec. | $36.68 | -3.46% |
SAGE : Sage Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $35.42 | -3.46% |
| 2028 Feb. | $34.23 | -3.34% |
| 2028 Mar. | $33.14 | -3.18% |
| 2028 Apr. | $32.15 | -3.00% |
| 2028 May. | $31.25 | -2.79% |
| 2028 Jun. | $30.45 | -2.56% |
| 2028 Jul. | $29.74 | -2.35% |
| 2028 Aug. | $29.09 | -2.20% |
| 2028 Sep. | $28.48 | -2.08% |
| 2028 Oct. | $27.90 | -2.02% |
| 2028 Nov. | $27.32 | -2.08% |
| 2028 Dec. | $26.71 | -2.25% |
SAGE : Sage Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $26.03 | -2.52% |
| 2029 Feb. | $25.30 | -2.80% |
| 2029 Mar. | $24.52 | -3.08% |
| 2029 Apr. | $23.71 | -3.31% |
| 2029 May. | $22.87 | -3.56% |
| 2029 Jun. | $22.04 | -3.60% |
| 2029 Jul. | $21.26 | -3.57% |
| 2029 Aug. | $20.52 | -3.45% |
| 2029 Sep. | $19.86 | -3.22% |
| 2029 Oct. | $19.30 | -2.86% |
| 2029 Nov. | $18.87 | -2.22% |
| 2029 Dec. | $18.65 | -1.17% |
SAGE : Sage Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $18.71 | 0.37% |
| 2030 Feb. | $19.14 | 2.28% |
| 2030 Mar. | $19.96 | 4.28% |
| 2030 Apr. | $21.13 | 5.85% |
| 2030 May. | $22.48 | 6.42% |
| 2030 Jun. | $23.88 | 6.22% |
| 2030 Jul. | $25.29 | 5.89% |
| 2030 Aug. | $26.65 | 5.41% |
| 2030 Sep. | $28.06 | 5.28% |
| 2030 Oct. | $29.56 | 5.33% |
| 2030 Nov. | $31.01 | 4.91% |
| 2030 Dec. | $32.48 | 4.74% |
SAGE : Sage Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $35.27 | 8.60% |
| 2031 Feb. | $40.20 | 13.98% |
| 2031 Mar. | $45.12 | 12.24% |
| 2031 Apr. | $49.72 | 10.20% |
| 2031 May. | $51.72 | 4.01% |
| 2031 Jun. | $51.29 | -0.83% |
| 2031 Jul. | $49.37 | -3.74% |
| 2031 Aug. | $46.80 | -5.21% |
| 2031 Sep. | $44.15 | -5.67% |
| 2031 Oct. | $41.74 | -5.45% |
| 2031 Nov. | $39.76 | -4.75% |
| 2031 Dec. | $38.33 | -3.59% |
SAGE : Sage Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $37.41 | -2.41% |
| 2032 Feb. | $36.90 | -1.35% |
| 2032 Mar. | $36.63 | -0.72% |
| 2032 Apr. | $36.38 | -0.69% |
| 2032 May. | $36.10 | -0.77% |
| 2032 Jun. | $35.93 | -0.48% |
| 2032 Jul. | $35.96 | 0.08% |
| 2032 Aug. | $36.21 | 0.70% |
| 2032 Sep. | $36.59 | 1.03% |
| 2032 Oct. | $36.97 | 1.04% |
| 2032 Nov. | $37.28 | 0.85% |
| 2032 Dec. | $37.54 | 0.70% |
SAGE : Sage Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $37.79 | 0.67% |
| 2033 Feb. | $38.08 | 0.75% |
Frequently Asked Questions about Sage Therapeutics stock forecast
Is Sage Therapeutics a good long term stock?
From Sage Therapeutics stock forecast , Sage Therapeutics (SAGE) stock can be a good investment choice. According to AIPickup, the Sage Therapeutics stock price forecast for 2023 Mar. is $46.9509202784134 From Sage Therapeutics stock forecast , Sage Therapeutics (SAGE) stock can be a good investment choice. According to AIPickup, the Sage Therapeutics stock price forecast for 2024 Feb. is $54.5468162373487 From Sage Therapeutics stock forecast , Sage Therapeutics (SAGE) stock can be a good investment choice. According to AIPickup, the Sage Therapeutics stock price forecast for 2027 Feb. is $46.3409918162585 From Sage Therapeutics stock forecast , Sage Therapeutics (SAGE) stock cannot be a good investment choice. According to AIPickup, the Sage Therapeutics stock price forecast for 2028 Feb. is $34.232326025381 From Sage Therapeutics stock forecast , Sage Therapeutics (SAGE) stock cannot be a good investment choice. According to AIPickup, the Sage Therapeutics stock price forecast for 2032 Feb. is $36.9011474212602 From Sage Therapeutics stock forecast , Sage Therapeutics (SAGE) stock cannot be a good investment choice. According to AIPickup, the Sage Therapeutics stock price forecast for 2033 Feb. is $38.0791663714694
Is Sage Therapeutics stock overvalued?
Sage Therapeutics (SAGE) stock is expected to go UP . Therefore, AIPickup would say that Sage Therapeutics (SAGE) stock is NOT overvalued.
Will Sage Therapeutics stock price go up?
Yes. The Sage Therapeutics stock price forecast for 2024 Feb. is $54.5468162373487
Is Sage Therapeutics stock a good buy now?
Since closing price on 2023-02-01 is $44.6599998474121 and forecast for 2024 Feb. is $54.55, Sage Therapeutics stock is a good 1 year investment.
14 Days Historical Data for Sage Therapeutics stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| SAGE stock price for 2023-01-12 | $45.31 | $41.13 | $40.56 | $45.36 |
| SAGE stock price for 2023-01-13 | $45.58 | $45.22 | $45.09 | $49.56 |
| SAGE stock price for 2023-01-17 | $44.04 | $45.58 | $43.67 | $45.81 |
| SAGE stock price for 2023-01-18 | $43.94 | $44.07 | $43.48 | $44.84 |
| SAGE stock price for 2023-01-19 | $42.55 | $43.78 | $42.52 | $43.88 |
| SAGE stock price for 2023-01-20 | $42.56 | $43.09 | $41.71 | $43.09 |
| SAGE stock price for 2023-01-23 | $42.66 | $42.38 | $41.76 | $42.99 |
| SAGE stock price for 2023-01-24 | $45.04 | $42.48 | $42.20 | $45.64 |
| SAGE stock price for 2023-01-25 | $44.51 | $44.62 | $43.65 | $45.47 |
| SAGE stock price for 2023-01-26 | $44.97 | $44.78 | $43.40 | $45.16 |
| SAGE stock price for 2023-01-27 | $43.37 | $45.09 | $43.35 | $45.38 |
| SAGE stock price for 2023-01-30 | $43.15 | $42.87 | $42.73 | $43.98 |
| SAGE stock price for 2023-01-31 | $44.34 | $43.16 | $42.96 | $44.44 |
| SAGE stock price for 2023-02-01 | $44.66 | $44.31 | $43.50 | $45.24 |